What’s Driving Innovation in Next-Generation Glucocorticoid...

agregó una foto Health

2026-07-29 09:37:21 -

What’s Driving Innovation in Next-Generation Glucocorticoid Therapies?

The rising prevalence of autoimmune disorders, chronic inflammatory diseases, respiratory conditions, and allergic disorders is driving the growth of the Glucocorticoids Market. However, the market also faces several challenges. Long-term use of glucocorticoids is associated with adverse effects such as osteoporosis, diabetes, hypertension, and adrenal suppression, which can limit treatment...

0 Commentarios 0 Acciones 3 Views 0 Vista previa